TrialBMC cancer2016

SPARC expression in patients with high-risk localized soft tissue sarcoma treated on a randomized phase II trial of neo/adjuvant chemotherapy.

Elizabeth J Davis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.